25 results on '"DeFrancesco, Laura"'
Search Results
2. Xenotransplantation: how close are we?
3. 3Q22 — more malaise in the markets
4. Nature Biotechnology’s academic spinouts 2021
5. Decentralized investor communities gain traction in biotech
6. Public biotech in 2022 — the numbers
7. Biotech patenting — 2022
8. Drug pipeline 3Q22 — rare disease and Alzheimer’s treatments
9. 2Q22 — Slip sliding away
10. Preparing for the next plague
11. 1Q22 — Blood in the water
12. 2021 — the bubble’s hangover
13. 3Q21—the market stalls
14. Drug pipeline 2Q22 — a downturn in approvals
15. Public biotech in 2021 — the numbers
16. Drug pipeline 1Q22 — a raft of new modalities … and clinical blowups
17. Drug pipeline 4Q21
18. Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
19. Vector BioPharma: resurrecting adenoviral gene delivery
20. Chroma Medicine and Tune Therapeutics: Two companies take up epigenome editing
21. Abalos Therapeutics---arenaviruses take on cancer
22. Drug pipeline 3Q21—mixed news for genetic therapies
23. Drug pipeline: 2Q18.
24. Erratum: Nature Biotechnology's academic spinouts of 2017.
25. Pheast Therapeutics: Another bite at the apple.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.